CeriBell, Inc. - SIC # 3840 -

Ticker Exchange SIC # Website Latest Ticker
CBLL Nasdaq 3840 ceribell.com

Select one of the four (4) financial statement analysis reports below to view the ratio analysis report for your selected company:

Financial Analysis - Public Company vs Industry Ratio Analysis
Financial Analysis - Public Company
Industry Ratios Analysis
Public Company vs Public Company

Latest Headlines for CeriBell, Inc.

Ceribell to Participate in the 43rd Annual J.P. Morgan Healthcare Conference - Dec 23rd, 2024 9:05 pm
Ceribell Appoints Kristie Rodenbush as Chief People Officer and Brian Price as Senior Vice President of Marketing - Nov 19th, 2024 1:00 pm
Meet the biophysicist whose seizure-detection company is using AI to get a better read on people’s brains - Nov 19th, 2024 12:01 pm
Ceribell, Inc. Reports Strong Q3 2024 Growth - Nov 14th, 2024 4:55 am
Ceribell Reports Third Quarter 2024 Financial Results - Nov 12th, 2024 9:05 pm
Ceribell Receives Authority to Operate from the U.S. Department of Veterans Affairs - Nov 11th, 2024 1:00 pm
Ceribell to Participate in the Canaccord Genuity MedTech, Diagnostics and Digital Health & Services Forum - Nov 7th, 2024 9:05 pm
Ceribell initiated with a Buy at BofA on ‘differentiated AI algorithm’ - Nov 6th, 2024 11:31 am
Ceribell to Report Third Quarter 2024 Financial Results on November 12, 2024 - Oct 29th, 2024 8:05 pm
New Clinical Evidence Links Ceribell Point-of-Care EEG to Shorter Hospital Stays and Better Functional Outcomes Compared to Conventional EEG - Oct 16th, 2024 8:05 pm
CeriBell, Inc. Announces Closing of Upsized Initial Public Offering and Full Exercise of the Underwriters' Option to Purchase Additional Shares - Oct 15th, 2024 9:00 pm
Opening Day: Another trio of biotech IPOs make Friday debut - Oct 14th, 2024 10:45 am
CeriBell IPO: Stock price soars as AI brain-monitoring headband maker debuts on Nasdaq - Oct 11th, 2024 2:15 pm
CeriBell, Inc. Announces Pricing of Upsized Initial Public Offering - Oct 11th, 2024 3:27 am